Vhlem1.1Yxy
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Vhlem1.1Yxy |
| Name: |
von Hippel-Lindau tumor suppressor; endonuclease-mediated mutation 1.1, Yuxin Yin |
| MGI ID: |
MGI:7572492 |
| Synonyms: |
Vhlmu |
| Gene: |
Vhl Location: Chr6:113600955-113608595 bp, + strand Genetic Position: Chr6, 52.81 cM
|
| Alliance: |
Vhlem1.1Yxy page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Not Specified) |
| Mutations: |
|
Insertion, Single point mutation
|
| |
|
Mutation details: CRISPR/Cas9 technology replaced exon 2 with a modified exon 2 containing an A to T missense mutation (c.349A>T) which results in an isoleucine to phenylalanine substitution at amino acid 117 (p.I117F) and a loxP-flanked neomycin-resistance gene following the mutant exon 2. The neomycin resistance gene was removed via cre-mediated recombination. The p.I117F mutation correlates to the p.I151F mutation in human.
(J:344096)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Vhl Mutation: |
17 strains or lines available
|
|
| Original: |
J:344096 Hao W, et al., Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease. Cell Death Dis. 2023 Oct 13;14(10):680 |
| All: |
1 reference(s) |
|